296 related articles for article (PubMed ID: 17762511)
1. Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect.
McLaughlin RJ; Hill MN; Morrish AC; Gorzalka BB
Behav Pharmacol; 2007 Sep; 18(5-6):431-8. PubMed ID: 17762511
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test.
Hill MN; Gorzalka BB
Eur Neuropsychopharmacol; 2005 Dec; 15(6):593-9. PubMed ID: 15916883
[TBL] [Abstract][Full Text] [Related]
3. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
Hartmann A; Fassini A; Scopinho A; Correa FM; Guimarães FS; Lisboa SF; Resstel LB
J Psychopharmacol; 2019 May; 33(5):606-614. PubMed ID: 30789299
[TBL] [Abstract][Full Text] [Related]
4. Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: role of gender and noradrenergic transmission.
Morrish AC; Hill MN; Riebe CJ; Gorzalka BB
Physiol Behav; 2009 Aug; 98(1-2):118-24. PubMed ID: 19414024
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis.
Hill MN; Ho WS; Sinopoli KJ; Viau V; Hillard CJ; Gorzalka BB
Neuropsychopharmacology; 2006 Dec; 31(12):2591-9. PubMed ID: 16710317
[TBL] [Abstract][Full Text] [Related]
6. Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours.
Roohbakhsh A; Keshavarz S; Hasanein P; Rezvani ME; Moghaddam AH
Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):333-8. PubMed ID: 19614892
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
Seillier A; Advani T; Cassano T; Hensler JG; Giuffrida A
Int J Neuropsychopharmacol; 2010 Apr; 13(3):373-86. PubMed ID: 19607756
[TBL] [Abstract][Full Text] [Related]
8. Involvement of CB
Sartim AG; Moreira FA; Joca SRL
Neuroscience; 2017 Jan; 340():126-134. PubMed ID: 27771531
[TBL] [Abstract][Full Text] [Related]
9. Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress.
Bedse G; Colangeli R; Lavecchia AM; Romano A; Altieri F; Cifani C; Cassano T; Gaetani S
Eur Neuropsychopharmacol; 2014 Sep; 24(9):1511-23. PubMed ID: 25106694
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of endocannabinoid metabolism attenuates enhanced hippocampal neuronal activity induced by kainic acid.
Coomber B; O'Donoghue MF; Mason R
Synapse; 2008 Oct; 62(10):746-55. PubMed ID: 18651640
[TBL] [Abstract][Full Text] [Related]
11. Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: the role of the endocannabinoid system.
Wang HN; Wang L; Zhang RG; Chen YC; Liu L; Gao F; Nie H; Hou WG; Peng ZW; Tan Q
J Psychiatr Res; 2014 Apr; 51():79-87. PubMed ID: 24479995
[TBL] [Abstract][Full Text] [Related]
12. Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice.
Ostadhadi S; Haj-Mirzaian A; Nikoui V; Kordjazy N; Dehpour AR
Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):203-12. PubMed ID: 26609670
[TBL] [Abstract][Full Text] [Related]
13. Estrogen recruits the endocannabinoid system to modulate emotionality.
Hill MN; Karacabeyli ES; Gorzalka BB
Psychoneuroendocrinology; 2007 May; 32(4):350-7. PubMed ID: 17391861
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine.
Guidali C; Viganò D; Petrosino S; Zamberletti E; Realini N; Binelli G; Rubino T; Di Marzo V; Parolaro D
Int J Neuropsychopharmacol; 2011 Feb; 14(1):17-28. PubMed ID: 20196921
[TBL] [Abstract][Full Text] [Related]
15. Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice.
Umathe SN; Manna SS; Jain NS
Behav Brain Res; 2011 Sep; 223(1):125-34. PubMed ID: 21549765
[TBL] [Abstract][Full Text] [Related]
16. Dorsal hippocampus cannabinoid type 1 receptors modulate the expression of contextual fear conditioning in rats: Involvement of local glutamatergic/nitrergic and GABAergic neurotransmissions.
Spiacci GB; Antero LS; Reis DG; Lisboa SF; Resstel LB
Eur Neuropsychopharmacol; 2016 Oct; 26(10):1579-89. PubMed ID: 27591981
[TBL] [Abstract][Full Text] [Related]
17. Acute activation of CB1 cannabinoid receptors transiently decreases PSA-NCAM expression in the dentate gyrus of the rat hippocampus.
Maćkowiak M; Chocyk A; Markowicz-Kula K; Wedzony K
Brain Res; 2007 May; 1148():43-52. PubMed ID: 17355876
[TBL] [Abstract][Full Text] [Related]
18. Sex, drugs, and adult neurogenesis: sex-dependent effects of escalating adolescent cannabinoid exposure on adult hippocampal neurogenesis, stress reactivity, and amphetamine sensitization.
Lee TT; Wainwright SR; Hill MN; Galea LA; Gorzalka BB
Hippocampus; 2014 Mar; 24(3):280-92. PubMed ID: 24132958
[TBL] [Abstract][Full Text] [Related]
19. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
Seillier A; Giuffrida A
Neuropharmacology; 2018 Mar; 130():1-9. PubMed ID: 29169961
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
Jiang HX; Ke BW; Liu J; Ma G; Hai KR; Gong DY; Yang Z; Zhou C
Anesth Analg; 2019 Aug; 129(2):587-597. PubMed ID: 29863609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
